Statistical Insights

Going Synthetic with Real-World Data

Going Synthetic with Real-World Data 260 200 Exploristics

Aiden Flynn, CEO 01 December 2019

Real-world data has the potential to have a positive impact on the treatment of serious conditions, providing much-needed insights into the health and treatment of patients in an everyday setting. However, the collection of

The liberation of real-world data

The liberation of real-world data 260 200 Exploristics

Aiden Flynn, CEO 01 December 2019

The costs and complexities associated with drug development are fuelling the drive for more efficient healthcare delivery. Using real-world data resources leads to better informed projects, improved patient outcomes and a more effective evaluation

Belfast is where Exploristics’ heart is

Belfast is where Exploristics’ heart is 260 200 Exploristics

Aiden Flynn, CEO 24 February 2021

As a business founder I am fascinated by the back stories of others who have decided to take a leap of faith and start their own businesses.  It takes incredible courage, tenacity, resilience and …

Statistical Insights: Why Getting Smaller Doesn’t Mean Thinking Smaller

Why Getting Smaller Doesn’t Mean Thinking Smaller

Why Getting Smaller Doesn’t Mean Thinking Smaller 260 200 Exploristics

Aiden Flynn, CEO 05 January 2021

In the wake of a tumultuous 2020, I have taken the opportunity to reflect on the progress Exploristics has made as a company and reappraise my reasons for setting it up. This seems fitting …

Statistical Insights: Clinical trials after COVID-19

Clinical trials after COVID-19

Clinical trials after COVID-19 260 200 Exploristics

Aiden Flynn, CEO 11 August 2020

The challenges faced by the Pharmaceutical Industry have been well documented: the high costs of clinical trials; the high rates of attrition; higher regulatory scrutiny; limited scope to pay high costs of new medicines; …

exploristics-statistical-insights-COVID-19

COVID-19: Where there’s a will there’s a way

COVID-19: Where there’s a will there’s a way 260 200 Exploristics

Aiden Flynn, CEO 7 July 2020

The COVID-19 pandemic has demonstrated the importance of science and the dedication of scientists in overcoming the challenges that we face. At Exploristics, we have been involved in multiple projects relating to the development …